11/20
07:07 am
vygr
Voyager Selects Tau Silencing Gene Therapy Development Candidate for Alzheimer's Disease [Yahoo! Finance]
Medium
Report
Voyager Selects Tau Silencing Gene Therapy Development Candidate for Alzheimer's Disease [Yahoo! Finance]
11/20
07:00 am
vygr
Voyager Selects Tau Silencing Gene Therapy Development Candidate for Alzheimer’s Disease
Medium
Report
Voyager Selects Tau Silencing Gene Therapy Development Candidate for Alzheimer’s Disease
11/18
03:07 am
vygr
Voyager Therapeutics, Inc. (NASDAQ: VYGR) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Medium
Report
Voyager Therapeutics, Inc. (NASDAQ: VYGR) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
11/14
11:23 am
vygr
Voyager Therapeutics, Inc. (NASDAQ: VYGR) had its "buy" rating re-affirmed by analysts at Canaccord Genuity Group Inc.. They now have a $14.00 price target on the stock.
Medium
Report
Voyager Therapeutics, Inc. (NASDAQ: VYGR) had its "buy" rating re-affirmed by analysts at Canaccord Genuity Group Inc.. They now have a $14.00 price target on the stock.
11/14
08:15 am
vygr
Voyager Therapeutics, Inc. (NASDAQ: VYGR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
Medium
Report
Voyager Therapeutics, Inc. (NASDAQ: VYGR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
11/14
06:59 am
vygr
Declining Stock and Decent Financials: Is The Market Wrong About Voyager Therapeutics, Inc. (NASDAQ:VYGR)? [Yahoo! Finance]
High
Report
Declining Stock and Decent Financials: Is The Market Wrong About Voyager Therapeutics, Inc. (NASDAQ:VYGR)? [Yahoo! Finance]
11/13
02:26 am
vygr
Voyager Therapeutics Inc (VYGR) Q3 2024 Earnings Call Highlights: Strong Cash Position and ... [Yahoo! Finance]
Medium
Report
Voyager Therapeutics Inc (VYGR) Q3 2024 Earnings Call Highlights: Strong Cash Position and ... [Yahoo! Finance]
11/12
04:01 pm
vygr
Voyager Reports Third Quarter 2024 Financial and Operating Results
Low
Report
Voyager Reports Third Quarter 2024 Financial and Operating Results
11/10
02:03 am
vygr
Voyager Therapeutics, Inc. (NASDAQ: VYGR) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Medium
Report
Voyager Therapeutics, Inc. (NASDAQ: VYGR) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
11/6
07:00 am
vygr
Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences
Medium
Report
Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences
11/5
07:00 am
vygr
Voyager Therapeutics Announces Third Quarter 2024 Conference Call and Webcast
Low
Report
Voyager Therapeutics Announces Third Quarter 2024 Conference Call and Webcast
11/2
02:10 am
vygr
Voyager Therapeutics, Inc. (NASDAQ: VYGR) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Medium
Report
Voyager Therapeutics, Inc. (NASDAQ: VYGR) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
10/28
11:40 am
vygr
Voyager Therapeutics (VYGR) Expected to Beat Earnings Estimates: Can the Stock Move Higher? [Yahoo! Finance]
Low
Report
Voyager Therapeutics (VYGR) Expected to Beat Earnings Estimates: Can the Stock Move Higher? [Yahoo! Finance]
10/25
11:05 pm
vygr
Voyager Therapeutics, Inc. (NASDAQ: VYGR) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Low
Report
Voyager Therapeutics, Inc. (NASDAQ: VYGR) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
10/24
03:27 pm
vygr
Voyager Therapeutics, Inc. (NASDAQ: VYGR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
Low
Report
Voyager Therapeutics, Inc. (NASDAQ: VYGR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
10/17
07:32 am
vygr
Voyager Therapeutics, Inc. (NASDAQ: VYGR) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
Low
Report
Voyager Therapeutics, Inc. (NASDAQ: VYGR) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
10/17
07:32 am
vygr
Voyager Therapeutics, Inc. (NASDAQ: VYGR) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
Low
Report
Voyager Therapeutics, Inc. (NASDAQ: VYGR) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
10/16
08:24 am
vygr
Voyager Therapeutics, Inc. (NASDAQ: VYGR) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $15.00 price target on the stock.
High
Report
Voyager Therapeutics, Inc. (NASDAQ: VYGR) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $15.00 price target on the stock.
10/14
08:23 am
vygr
Investing in Voyager Therapeutics (NASDAQ:VYGR) three years ago would have delivered you a 58% gain [Yahoo! Finance]
Low
Report
Investing in Voyager Therapeutics (NASDAQ:VYGR) three years ago would have delivered you a 58% gain [Yahoo! Finance]
10/11
11:09 pm
vygr
Voyager Therapeutics, Inc. (NASDAQ: VYGR) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Low
Report
Voyager Therapeutics, Inc. (NASDAQ: VYGR) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
10/7
07:13 am
vygr
Strength Seen in Voyager Therapeutics (VYGR): Can Its 17.5% Jump Turn into More Strength? [Yahoo! Finance]
Medium
Report
Strength Seen in Voyager Therapeutics (VYGR): Can Its 17.5% Jump Turn into More Strength? [Yahoo! Finance]
9/16
07:00 am
vygr
Voyager Advances Collaboration with Neurocrine; Third Gene Therapy Development Candidate Selected
Low
Report
Voyager Advances Collaboration with Neurocrine; Third Gene Therapy Development Candidate Selected
9/5
08:00 am
vygr
Voyager Enters into License for Next-Generation Capsid, Bringing Partnered Portfolio of TRACER-Enabled Gene Therapies to 14
Neutral
Report
Voyager Enters into License for Next-Generation Capsid, Bringing Partnered Portfolio of TRACER-Enabled Gene Therapies to 14
8/29
04:01 pm
vygr
Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
8/29
07:00 am
vygr
Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences
Medium
Report
Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences